306 related articles for article (PubMed ID: 30340769)
1. Gender Identity, Hormone Therapy, and Cardiovascular Disease Risk.
Martinez C; Rikhi R; Haque T; Fazal A; Kolber M; Hurwitz BE; Schneiderman N; Brown TT
Curr Probl Cardiol; 2020 May; 45(5):100396. PubMed ID: 30340769
[TBL] [Abstract][Full Text] [Related]
2. Foreword.
Curr Probl Cardiol; 2020 May; 45(5):100559. PubMed ID: 32192631
[No Abstract] [Full Text] [Related]
3. Cardiovascular disease in transgender people: recent research and emerging evidence.
Connelly PJ; Delles C
Cardiovasc Res; 2021 Dec; 117(14):e174-e176. PubMed ID: 34568899
[No Abstract] [Full Text] [Related]
4. Cardiovascular implications of gender-affirming hormone treatment in the transgender population.
Dutra E; Lee J; Torbati T; Garcia M; Merz CNB; Shufelt C
Maturitas; 2019 Nov; 129():45-49. PubMed ID: 31547912
[TBL] [Abstract][Full Text] [Related]
5. [Transgender, transsexualism and gender dysphoria: current developments in diagnostics and health care].
Nieder TO; Briken P; Richter-Appelt H
Psychother Psychosom Med Psychol; 2014 Jun; 64(6):232-45. PubMed ID: 24892869
[No Abstract] [Full Text] [Related]
6. Transgender men: clinical care and implications in reproductive medicine: introduction.
de Ziegler D; de Sutter P
Fertil Steril; 2021 Oct; 116(4):919-921. PubMed ID: 34399947
[TBL] [Abstract][Full Text] [Related]
7. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
Ong C; Monita M; Liu M
Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
[TBL] [Abstract][Full Text] [Related]
8. Gender identity and the management of the transgender patient: a guide for non-specialists.
Joseph A; Cliffe C; Hillyard M; Majeed A
J R Soc Med; 2017 Apr; 110(4):144-152. PubMed ID: 28382847
[TBL] [Abstract][Full Text] [Related]
9. [Psychiatric comorbidities in transsexualism: Study of a Lebanese transgender population].
Ibrahim C; Haddad R; Richa S
Encephale; 2016 Dec; 42(6):517-522. PubMed ID: 27017319
[TBL] [Abstract][Full Text] [Related]
10. Update on Gender-Affirming Treatment for the Transgender Woman.
Unger CA
Semin Reprod Med; 2017 Sep; 35(5):442-447. PubMed ID: 29073683
[No Abstract] [Full Text] [Related]
11. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
Karalexi MA; Georgakis MK; Dimitriou NG; Vichos T; Katsimpris A; Petridou ET; Papadopoulos FC
Psychoneuroendocrinology; 2020 Sep; 119():104721. PubMed ID: 32512250
[TBL] [Abstract][Full Text] [Related]
12. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
[TBL] [Abstract][Full Text] [Related]
13. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
14. Priorities for transgender medical and healthcare research.
Feldman J; Brown GR; Deutsch MB; Hembree W; Meyer W; Meyer-Bahlburg HF; Tangpricha V; TʼSjoen G; Safer JD
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):180-7. PubMed ID: 26825469
[TBL] [Abstract][Full Text] [Related]
15. [Treating transgender minors with hormones: obstacles in medical ethics today].
Bernier A; Leplège A
Med Sci (Paris); 2018; 34(6-7):595-598. PubMed ID: 30067215
[No Abstract] [Full Text] [Related]
16. Research priorities for gender nonconforming/transgender youth: gender identity development and biopsychosocial outcomes.
Olson-Kennedy J; Cohen-Kettenis PT; Kreukels BP; Meyer-Bahlburg HF; Garofalo R; Meyer W; Rosenthal SM
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):172-9. PubMed ID: 26825472
[TBL] [Abstract][Full Text] [Related]
17. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
Rowniak S; Bolt L; Sharifi C
JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1826-1854. PubMed ID: 31021971
[TBL] [Abstract][Full Text] [Related]
18. Masculinizing gender-affirming surgery for trans men and non-binary individuals: what you should know.
Patel DP; Goodwin IA; Acar O; Kocjancic E; Hotaling JM
Fertil Steril; 2021 Oct; 116(4):924-930. PubMed ID: 34404544
[TBL] [Abstract][Full Text] [Related]
19. Sex, Gender, and Transgender: Metabolic Impact of Cross Hormone Therapy.
de Souza Santos R; Frank AP; Nelson MD; Garcia MM; Palmer BF; Clegg DJ
Adv Exp Med Biol; 2017; 1043():611-627. PubMed ID: 29224113
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
Aranda G; Halperin I; Gomez-Gil E; Hanzu FA; Seguí N; Guillamon A; Mora M
Front Endocrinol (Lausanne); 2021; 12():718200. PubMed ID: 34659112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
